A doctor administers Thymosin Beta-4 peptides to a patient via subcutaneous injection.

Key Takeaways

  • Thymosin Beta-4 is a naturally occurring peptide found in nearly all human cells. It is released by platelets and macrophages after injury to support tissue repair
  • TB-4 is the full 43-amino-acid peptide; TB-500 is a shorter synthetic fragment derived from TB-4’s active region that mimics some but not all of its biological effects
  • Key benefits supported by research include musculoskeletal healing, anti-inflammatory activity, cardiac tissue protection, and wound healing. But evidence levels vary by application
  • TB-4 has not been proven to cause cancer, but its mechanism promotes cell migration and angiogenesis, which are processes also involved in tumor progression. Side effects are generally mild: temporary fatigue, injection site reactions, and occasional headache or nausea
  • TB-4 is legal in Thailand when prescribed and administered in a licensed clinical setting. However, it is prohibited by WADA under the S2 category for competitive athletes

Regenerative medicine’s landscape prominently features Thymosin Beta-4. The thymosin beta 4 peptide, a well-researched protein, can be used for healing injuries, managing inflammation, and regenerating tissue. Additionally, it stands out as one of the few in peptide therapy with human phase 2 data, but what are its functions, and is it safe?

In this guide, we cover the mechanism, thymosin beta 4 benefits, realistic expectations for dosage, side effects, its legal status in Thailand, and other things you should know.

What Is Thymosin Beta-4?

Thymosin Beta-4 is a naturally occurring 43-amino-acid peptide found in nearly all human and animal cells, with particularly high concentrations in platelets and wound fluid. When tissue damage occurs, TB-4 is released by platelets, macrophages, and other cell types as one of the body’s first responders to injury. Its primary role is actin sequestration: binding actin monomers to regulate cell structure and movement, thereby controlling cell migration and being fundamental to tissue repair.

After injury, TB-4 protects cells from further damage, reduces apoptosis and inflammation, inhibits microbial growth, and promotes the mobilization of stem and progenitor cells that form new blood vessels and regenerate tissue. It’s distinct from Thymosin Alpha-1, which primarily modulates the immune system, whereas TB-4 focuses specifically on tissue repair and regeneration.

TB-4 vs. TB-500: What’s the Difference?

  • Thymosin Beta-4 is the full, naturally occurring 43-amino-acid peptide. It’s produced in the body and plays a direct role in tissue repair, reducing inflammation, and promoting angiogenesis.
  • TB-500 is a synthetic peptide derived from the active region of TB-4. It’s shorter and was designed for greater stability and wider distribution throughout the body. TB-500 mimics some but not all of TB-4’s biological effects.

In practical terms, TB-4 is the complete natural peptide, while TB-500 is a synthetic fragment engineered to replicate its key actions. Both appear in the research literature and are discussed in regenerative medicine contexts. If you’re researching TB-500, be aware that these compounds are related but distinct.

Thymosin Beta-4 Benefits

TB-4’s therapeutic profile spans several areas. Here’s what the research shows for thymosin beta-4’s benefits.

Musculoskeletal Healing

This is TB-4’s most studied application. It accelerates the repair of tendons, ligaments, and muscle tissue. A study published in The FASEB Journal demonstrated that TB-4 increased re-epithelialization by 42% over controls at 4 days and by up to 61% at 7 days in a rat wound model, with increased collagen deposition and angiogenesis in treated wounds. The mechanism involves promoting cell migration and stimulating keratinocyte movement to the injury site.

Anti-Inflammatory Activity

TB-4 reduces both localized and systemic inflammation. A review in Frontiers in Pharmacology describes its role in decreasing apoptosis, reducing inflammatory signaling, and inhibiting fibrosis. This makes it relevant for chronic pain conditions and post-surgical recovery, where persistent inflammation delays healing.

Cardiac Tissue Repair

Animal studies have shown a protective effect on heart tissue following ischemic injury. Research published in Nature found that TB-4 induced mobilization of adult epicardial progenitors and neovascularization in mouse hearts. This line of research positions TB-4 as a potential therapeutic agent for cardiac repair, though human cardiac trials are still in progress.

Neuroprotection

Early evidence suggests TB-4 supports nerve repair and neurotransmitter regulation. Preclinical studies have explored its potential in brain tissue repair following stroke and trauma. This is an emerging area with promising mechanistic data but limited clinical application so far.

Skin and Wound Healing

TB-4 promotes cell migration to wound sites and reduces scarring by decreasing myofibroblast numbers in wounds. Research published in Vitamins and Hormones reports that TB-4 accelerated dermal healing in preclinical models, including diabetic and aged animals, and in phase 2 clinical trials for patients with pressure ulcers, stasis ulcers, and epidermolysis bullosa wounds. The study concluded it was safe and well-tolerated.

Thymosin Beta-4 Dosage: What Protocols Look Like

A doctor discusses the procedure and protocols for Thymosin Beta-4 with a patient.

TB-4 is typically dosed in the microgram-to-milligram range, depending on the indication and the patient’s health profile. There is no single standardized dosing protocol, making physician oversight important.

Common administration involves subcutaneous injection, either daily or several times weekly. For musculoskeletal targets, local injection at or near the injury site may be used. Cycle length varies based on the condition being treated: short acute courses for injury recovery; longer maintenance protocols for chronic conditions or broader regenerative goals.

Specific numeric doses are physician-determined and individualized. What works for post-surgical recovery in one patient won’t necessarily be appropriate for a chronic inflammatory condition in another. Throughout the protocol, monitoring includes response assessment and tolerance check-ins to adjust dosing as needed.

Does Thymosin Beta-4 Cause Cancer?

This question comes up fairly often, in part because TB-4 promotes cell migration and angiogenesis, which are the same processes involved in tumor progression.

Fortunately, research shows that no causal link between TB-4 and cancer development has been established. A Haematologica study on multiple myeloma found that TB-4 expression was lower in myeloma cells than in normal cells, and that overexpression of TB-4 in myeloma cells decreased their proliferative and migratory capacity.

That said, the absence of a causal link isn’t proof of safety across all populations. If you have an active malignancy or a history of hormone-sensitive cancers, TB-4 is not a recommended course of treatment.

Thymosin Beta-4 Side Effects

TB-4 is generally well tolerated in clinical use. Its side-effect profile is mild relative to many pharmaceutical interventions, consistent with its status as a naturally occurring peptide already present in the body.

Reported effects include:

  • Temporary fatigue or lethargy: Most commonly reported early in the protocol, typically resolving within the first few days
  • Injection site reactions: Mild redness, swelling, or discomfort at the injection area; usually transient
  • Headache: Rare; typically mild and short-lived
  • Nausea: Rare; tends to occur during initial dosing and diminish with continued use

TB-4 is not suitable for patients with active cancer, pregnancy, or specific autoimmune conditions. A pre-treatment evaluation is required to rule out contraindications.

Side-effect risk is meaningfully reduced with appropriate dosing and medical supervision. The most common problems reported in unmonitored use stem from incorrect dosing or unverified product quality, not from the peptide’s inherent profile.

Thailand does not restrict Thymosin Beta-4 in the same way as the US FDA, which has limited the activities of compounding pharmacies around certain peptides. In Thailand, TB-4 can be legally prescribed and administered in licensed clinical settings under physician supervision.

WADA note: Thymosin Beta-4 and its derivatives, including TB-500, are listed on the World Anti-Doping Agency’s Prohibited List under the S2 category. They are prohibited at all times, both in and out of competition, for competitive athletes. But for non-competitive patients, you can legally access TB-4 through licensed Thai medical clinics with a physician’s prescription.

Rejuvenate Your Health with Thymosin Beta-4

Thymosin Beta-4 has a strong preclinical profile for tissue repair, inflammation control, and regeneration, supported by phase 2 clinical trial data in dermal wound healing. While there’s no causal link established between TB-4 and cancer, getting a pre-treatment screening is still necessary given how the peptide works. For the best outcomes and peace of mind, you’ll want to have the right clinic.

H.U.M. Clinic administers pharmaceutical-grade Thymosin Beta-4 under physician supervision with ISO 9001:2015 certified quality standards. Every protocol is individualized based on your health assessment, with ongoing monitoring and follow-up throughout treatment.

Visit H.U.M. Clinic for a trusted peptide therapy consultation at a clinic in Bangkok to find out if Thymosin Beta-4 is right for your health goals. Contact us via LINE, WhatsApp, phone at 098 983 2949, or email at [email protected]. Our team is here to help every step of the way.

References

  1. Thymosin Beta-4: A Multi-Functional Regenerative Peptide. Basic Properties and Clinical Applications. Retrieved on 24 March 2026 from https://pubmed.ncbi.nlm.nih.gov/22074294/
  2. Progress on the Function and Application of Thymosin Beta-4. Retrieved on 24 March 2026 from https://pmc.ncbi.nlm.nih.gov/articles/PMC8724243/
  3. Thymosin Beta-4 Accelerates Wound Healing. Retrieved on 24 March 2026 from https://pubmed.ncbi.nlm.nih.gov/10469335/
  4. Thymosin Beta-4 Promotes Dermal Healing. Retrieved on 24 March 2026 from https://pubmed.ncbi.nlm.nih.gov/27450738/
  5. Advances in the Basic and Clinical Applications of Thymosin Beta-4. Retrieved on 24 March 2026 from https://pubmed.ncbi.nlm.nih.gov/26096726/
  6. Thymosin Beta-4 Has Tumor Suppressive Effects and Its Decreased Expression Results in Poor Prognosis and Decreased Survival in Multiple Myeloma. Retrieved on 24 March 2026 from https://pmc.ncbi.nlm.nih.gov/articles/PMC2805724/
  7. The Prohibited List | World Anti Doping Agency. Retrieved on 24 March 2026 from https://www.wada-ama.org/en/prohibited-list

Frequently Asked Questions About Thymosin Beta-4

What is Thymosin Beta-4 used for?

Thymosin Beta-4 is used primarily for tissue repair, injury recovery, and inflammation control. Its most studied application is musculoskeletal healing, including tendon, ligament, and muscle repair. It has also demonstrated benefits in wound healing and shows early promise in cardiac tissue repair and neuroprotection. It is administered under physician supervision as part of a structured treatment protocol.

What is the difference between TB-4 and TB-500?

Thymosin Beta-4 is the full, naturally occurring 43-amino-acid peptide produced in the body. TB-500 is a shorter synthetic peptide derived from TB-4’s active region, designed for greater stability and distribution. TB-500 mimics some but not all of TB-4’s biological effects. H.U.M. Clinic administers Thymosin Beta-4, the complete peptide.

Yes. Thymosin Beta-4 can be legally prescribed and administered in licensed clinical settings in Thailand under physician supervision. It is listed on the WADA Prohibited List under S2 and is banned at all times for competitive athletes subject to drug testing. Non-competitive patients can access TB-4 through licensed medical clinics.